文献速递生殖医学

单原核合子囊胚培养与植入前遗传学筛查后的临床应用及双亲染色体遗传验证

Clinical use of monopronucleated zygotes following blastocyst culture and preimplantation genetic screening, including verification of biparental chromosome inheritance.
PubMed 文献 · Reprod Biomed Online · 2017-03-27

分析单原核(1PN)合子来源胚胎用于植入前遗传学筛查(PGS)的结局。1PN与2PN第5天囊胚形成率在IVF为14.8%对36.4%(P<0.0001),在ICSI为6.6%对34.0%(P<0.0001)。对74枚IVF和32枚ICSI来源1PN囊胚行PGS,校正异常率分别为39.7%和40.6%;20枚IVF和6枚ICSI 1PN囊胚单胚胎移植后获9例临床妊娠。

要点

  • 1PN来源胚胎囊胚形成率显著低于2PN胚胎,IVF为14.8%对36.4%,ICSI为6.6%对34.0%(均P<0.0001)。
  • 1PN来源囊胚PGS校正异常率IVF为39.7%、ICSI为40.6%。
  • 1枚ICSI来源1PN囊胚显示仅父源贡献,存在完全性葡萄胎妊娠风险。

核心结论

  • 已证实整倍体和双亲遗传的1PN来源胚胎可提供临床可用的胚胎来源。

研究设计与样本

  • 对指定用于PGS的1PN来源胚胎的结局进行分析。
  • 采用比较基因组杂交或下一代测序进行PGS,并对部分1PN来源囊胚检测双亲遗传。

主要发现

  • IVF来源1PN与2PN第5天囊胚形成率分别为14.8%和36.4%(P<0.0001)。
  • ICSI来源1PN与2PN第5天囊胚形成率分别为6.6%和34.0%(P<0.0001)。
  • PGS成功检测74枚IVF和32枚ICSI来源1PN囊胚,校正异常率分别为39.7%和40.6%。
  • 24枚女性1PN来源囊胚行双亲遗传检测,其中1枚ICSI来源胚胎显示仅父源贡献。
  • 20枚IVF和6枚ICSI来源1PN囊胚(未检出异常)行单胚胎移植,获9例临床妊娠,其中6例已分娩、3例持续妊娠,至今未报告异常。

关键数值与推荐

  • 1PN与2PN第5天囊胚形成率IVF为14.8%对36.4%(P<0.0001)。
  • 1PN与2PN第5天囊胚形成率ICSI为6.6%对34.0%(P<0.0001)。
  • IVF来源1PN囊胚PGS校正异常率为39.7%。
  • ICSI来源1PN囊胚PGS校正异常率为40.6%。

临床怎么用

  • 作者认为,已证实整倍体和双亲遗传的1PN来源胚胎可提供临床可用的胚胎来源。

局限性

  • 本研究的局限性在于原核状态仅通过一次静态观察确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

In assisted reproduction, embryos derived from monopronucleated (1PN) zygotes are considered abnormal and unsuitable for clinical use. Outcomes of 1PN-derived embryos designated for preimplantation genetic screening (PGS) were analysed. These embryos, especially from intracytoplasmic sperm injection (ICSI), were found to have a low developmental potential; 1PN and 2PN day 5 blastocyst development for IVF was 14.8% versus 36.4% (P < 0.0001), and for ICSI, 6.6% versus 34.0% (P < 0.0001), respectively. With the use of comparative genomic hybridization or next-generation sequencing, PGS was successfully carried out for 74 IVF and 32 ICSI 1PN-derived blastocysts, revealing adjusted abnormality rates of 39.7% and 40.6%, respectively. Additionally, 24 female 1PN-derived blastocysts underwent testing for biparental inheritance, with one ICSI-derived embryo demonstrating paternal only contribution, thus presenting a risk for complete hydatidiform molar pregnancy. Single embryo transfer of 20 IVF and six ICSI 1PN-derived blastocysts with no detectable abnormalities resulted in nine clinical pregnancies. Six have been delivered and three are ongoing, with no anomalies reported to date. The limitation of this study is that pronuclear status was determined through one static observation. The results suggest that 1PN-derived embryos, in which euploidy and biparental inheritance have been established, can provide a source of clinically useful embryos.

来源:Reprod Biomed Online,查看原文。版权归原作者所有。

引用

  1. Bradley CK, Traversa MV, Hobson N, et al. Clinical use of monopronucleated zygotes following blastocyst culture and preimplantation genetic screening, including verification of biparental chromosome inheritance. Reprod Biomed Online. 2017. PMID: 28431828. doi:10.1016/j.rbmo.2017.03.013

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。